The FINGER trial: can lifestyle change the trajectory?

It’s one thing to observe that healthy people get less dementia. It’s another to test whether changing behavior actually helps. The FINGER trial is among the most influential attempts to do exactly that, and its result is a reason for cautious optimism.

What FINGER did

FINGER (the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) was a randomized controlled trial in adults aged 60 to 77 who were at risk of decline. Over two years, one group received a multidomain intervention that combined:

• Nutritional guidance
• Physical exercise
• Cognitive training
• Monitoring and management of vascular/metabolic risk factors

…while a control group received general health advice.

What it found

The multidomain group maintained or improved cognitive performance relative to control, a modest but statistically significant difference on the neuropsychological test battery. The headline lesson is not any single ingredient. It’s that a combined, real-world lifestyle program can benefit cognition in at-risk older adults. The trial helped move dementia prevention from “plausible” toward “actionable,” and inspired a network of similar trials worldwide.

Why it matters for APOE4 carriers

• It supports the central premise of this site: the modifiable levers, pursued together, may meaningfully influence the trajectory, consistent with the WHO’s emphasis on dementia risk reduction.
• The intervention is essentially the package we cover throughout: diet, exercise, cognitive and social engagement, and vascular health, rather than a pill or a single hack.

The honest caveats

• FINGER measured cognitive performance over two years, not a lifetime of dementia outcomes. Longer and broader trials are ongoing.
• Effects were at the group level, and individuals vary.
• It wasn’t an APOE4-specific trial, though later analyses have explored genotype, and carrier-focused research continues.

The takeaway is empowering and well-grounded: a combined lifestyle program can support cognition in at-risk adults. For carriers, that’s the strongest kind of motivation, evidence that the levers you control are worth pulling, together and early.